Rebecca Galla

A Sequential Gut–Pancreas–Liver In Vitro Model to Evaluate the Multi-Target Metabolic Effects of a Nutraceutical Formulation in MASLD-Related Conditions

Background/Objectives: Metabolically dysregulated-associated steatotic liver disease (MASLD) is a complex, multifactorial disorder characterised by hepatic lipid accumulation, insulin resistance, oxidative stress, and dysfunction of the gut–liver axis. Given its intricate pathoph...